Martingale Asset Management’s ALX Oncology ALXO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-36,195
| Closed | -$404K | – | 785 |
|
|
2024
Q1 | $404K | Sell |
36,195
-5,914
| -14% | -$65.9K | 0.01% | 657 |
|
|
2023
Q4 | $627K | Sell |
42,109
-2,500
| -6% | -$37.2K | 0.01% | 556 |
|
|
2023
Q3 | $214K | Hold |
44,609
| – | – | ﹤0.01% | 740 |
|
|
2023
Q2 | $335K | Hold |
44,609
| – | – | 0.01% | 680 |
|
|
2023
Q1 | $202K | Hold |
44,609
| – | – | ﹤0.01% | 780 |
|
|
2022
Q4 | $503K | Sell |
44,609
-3
| -0% | -$34 | 0.01% | 613 |
|
|
2022
Q3 | $427K | Buy |
44,612
+2,679
| +6% | +$25.6K | 0.01% | 647 |
|
|
2022
Q2 | $340K | Buy |
+41,933
| New | +$340K | 0.01% | 717 |
|